Neonatal bone mass: influence of parental birthweight, maternal smoking, body composition, and activity during

K Godfrey1, K Walker-Bone, S Robinson

  • 1MRC Environmental Epidemiology Unit, University of Southampton, United Kingdom.

Insights

Parental factors and maternal lifestyle during pregnancy significantly impact infant bone development. These intrauterine influences may affect an individual

Area of Science:

  • Reproductive Medicine
  • Pediatric Endocrinology
  • Osteoporosis Research

Background:

  • Intrauterine growth and development are increasingly recognized as critical determinants of adult bone health.
  • Understanding prenatal influences on skeletal development is essential for early osteoporosis risk assessment.

Purpose of the Study:

  • To investigate maternal and paternal contributions to intrauterine skeletal growth in neonates.
  • To identify prenatal factors associated with neonatal bone mineral content (BMC) and bone mineral density (BMD).

Main Methods:

  • Dual-energy X-ray absorptiometry (DXA) was used to measure neonatal whole body BMC and BMD in 145 term infants.
  • Maternal and paternal factors, including parental birthweights, paternal height, and maternal lifestyle (smoking, physical activity, body composition), were assessed.

Main Results:

  • Paternal height and parental birthweights positively correlated with neonatal whole body BMC, independent of gestational age.
  • Maternal smoking during pregnancy was associated with significantly lower neonatal whole body BMC and BMD.
  • Maternal thinness, faster walking pace, and increased vigorous physical activity in late pregnancy were linked to lower neonatal BMC and BMD.

Conclusions:

  • Both genetic (parental size) and intrauterine environmental factors (maternal lifestyle) influence prenatal skeletal development.
  • Maternal behaviors such as smoking and physical activity during pregnancy can impact infant bone accrual.
  • Early-life environmental modulation may play a role in mitigating the risk of adult osteoporosis.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...